Sight Sciences, Inc. (SGHT)

Sight Sciences: Signs Of Progress, But Plenty Of Work Remains

Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting

Sight Sciences (NASDAQ:SGHT) Hits New 1-Year High – Should You Buy?

Sight Sciences, Inc. (SGHT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

BlackRock Inc. Purchases New Shares in Sight Sciences, Inc. $SGHT

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15

TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease

Sight Sciences, Inc. (SGHT) Q2 2026 Earnings Call Transcript

Sight Sciences Q2 Earnings Call Highlights

Sight Sciences Q2 Earnings Call Highlights

Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates

Sight Sciences (SGHT) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Sight Sciences Reports Second Quarter 2026 Financial Results

Sight Sciences Announces Aetna Coverage for OMNI and SION Surgical Systems

Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System

Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026